Amanda Hays is a Scientific Officer and Senior Director at BioAgilytix Laboratories. She offers more than a decade of lab experience in multiple fields, including pharmacology, drug metabolism, immunoassays, immunogenicity, biomarkers, flow cytometry and qPCR and has supported programs through all stages in drug development. In her current role, she provides global scientific leadership and technical guidance. Dr. Hays is the Chair of the AAPS Biomarkers and Precision Medicine community and the AAPS qPCR working group. She earned her Ph.D. in Pharmacology from the University of Kansas Medical Center.
